Biosysen Limited (HKG:1355)
Hong Kong
· Delayed Price · Currency is HKD 0.135
+0.008 (6.30%)
Apr 29, 2026, 3:36 PM HKT
Biosysen Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -21.12 | -38.18 | -7.79 | 4.98 | Upgrade
|
| Depreciation & Amortization | - | 24.03 | 29.16 | 30.65 | 30.11 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 30.82 | 41.76 | - | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 2.01 | 1.86 | -1.42 | -2.75 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -13.71 | 14.57 | 0.21 | - | Upgrade
|
| Other Operating Activities | - | -10.33 | -17.79 | -4.01 | -0.75 | Upgrade
|
| Change in Accounts Receivable | - | 12.6 | 3.04 | -12.23 | -7.15 | Upgrade
|
| Change in Inventory | - | -0.03 | -0.04 | 0.01 | -0.26 | Upgrade
|
| Change in Accounts Payable | - | - | - | 4.38 | 5.29 | Upgrade
|
| Change in Other Net Operating Assets | - | - | 0.77 | -0.44 | 0.91 | Upgrade
|
| Operating Cash Flow | - | 24.27 | 35.16 | 9.35 | 30.4 | Upgrade
|
| Operating Cash Flow Growth | - | -30.98% | 276.12% | -69.25% | 51.68% | Upgrade
|
| Capital Expenditures | - | -0.26 | -0.65 | -2.94 | -16.34 | Upgrade
|
| Other Investing Activities | - | 0.01 | 0 | 0.01 | 0.03 | Upgrade
|
| Investing Cash Flow | - | -0.25 | -0.64 | -2.93 | -16.31 | Upgrade
|
| Short-Term Debt Issued | - | 1.1 | - | 4.7 | 17.87 | Upgrade
|
| Total Debt Issued | - | 1.1 | - | 4.7 | 17.87 | Upgrade
|
| Short-Term Debt Repaid | - | -10.17 | -12.68 | -0.33 | -14.48 | Upgrade
|
| Long-Term Debt Repaid | - | -17.89 | -22.26 | -23.38 | -23.2 | Upgrade
|
| Total Debt Repaid | - | -28.07 | -34.94 | -23.71 | -37.68 | Upgrade
|
| Net Debt Issued (Repaid) | - | -26.97 | -34.94 | -19.01 | -19.81 | Upgrade
|
| Issuance of Common Stock | - | 14.99 | - | - | - | Upgrade
|
| Financing Cash Flow | - | -11.98 | -34.94 | -19.01 | -19.81 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.4 | 0.21 | 0.73 | 0.05 | Upgrade
|
| Net Cash Flow | - | 11.64 | -0.22 | -11.86 | -5.67 | Upgrade
|
| Free Cash Flow | - | 24.01 | 34.51 | 6.41 | 14.06 | Upgrade
|
| Free Cash Flow Growth | - | -30.42% | 438.41% | -54.41% | - | Upgrade
|
| Free Cash Flow Margin | - | 59.02% | 51.01% | 10.17% | 19.92% | Upgrade
|
| Free Cash Flow Per Share | - | 0.05 | 0.08 | 0.01 | 0.03 | Upgrade
|
| Cash Income Tax Paid | - | 0.25 | 3.08 | 2.51 | 3.29 | Upgrade
|
| Levered Free Cash Flow | - | 11.14 | 22.46 | 7.96 | 30.41 | Upgrade
|
| Unlevered Free Cash Flow | - | 14.8 | 26.06 | 12.56 | 35.46 | Upgrade
|
| Change in Working Capital | - | 12.57 | 3.77 | -8.28 | -1.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.